- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Patent holdings for IPC class A61K 47/68
Total number of patents in this class: 14248
10-year publication summary
|
570
|
997
|
1224
|
1208
|
1429
|
1489
|
1578
|
1714
|
1834
|
1109
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4698 |
247 |
| SeaGen Inc | 533 |
241 |
| Daiichi Sankyo Company, Limited | 1893 |
232 |
| Genentech, Inc. | 4099 |
204 |
| Hanmi Pharm. Co., Ltd. | 601 |
157 |
| Dyne Therapeutics, Inc. | 259 |
149 |
| MedImmune Limited | 610 |
143 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 383 |
126 |
| ImmunoGen, Inc. | 379 |
125 |
| The Regents of the University of California | 20720 |
122 |
| Bristol-myers Squibb Company | 4729 |
107 |
| Novartis AG | 10263 |
92 |
| Bolt Biotherapeutics, Inc. | 113 |
87 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 712 |
75 |
| Sanofi | 4293 |
71 |
| Hoffmann-La Roche Inc. | 3783 |
70 |
| Pfizer Inc. | 3384 |
70 |
| Memorial Sloan-Kettering Cancer Center | 2038 |
70 |
| Genmab A/S | 473 |
70 |
| Zymeworks Inc. | 253 |
69 |
| Other owners | 11721 |